Stable mammalian cell lines harboring a synthetic bovine opsin gene have been derived from the suspension-adapted HEK293 cell line. The opsin gene is under the control of the immediate-early cytomegalovirus promoter/enhancer in an expression vector that also contains a selectable marker (Neo) governed by a relatively weak promoter. The cell lines expressing the opsin gene at high levels are selected by growth in the presence of high concentrations of the antibiotic geneticin. Under the conditions used for cell growth in suspension, opsin is produced at saturated culture levels of more than 2 mg/liter. After reconstitution with 11-cis-retinal, rhodopsin is purified to homogeneity in a single step by immunoaffinity column chromatography. Rhodopsin thus prepared (>90% recovery at concentrations of up to 15 ,uM) is indistinguishable from rhodopsin purified from bovine rod outer segments by the following criteria: (i) UV/Vis absorption spectra in the dark and after photobleaching and the rate of metarhodopsin II decay, (ii) initial rates of transducin activation, and (iii) the rate of phosphorylation by rhodopsin kinase. Although mammalian cell opsin migrates slower than rod outer segment opsin on SDS/polyacrylamide gels, presumably due to a different N-glycosylation pattern, their mobilities after deglycosylation are identical. This method has enabled the preparation of several site-specific mutants of bovine opsin in comparable amounts.
Wild-type bovine rhodopsin is readily available in relatively large amounts. However, structure-function studies require mutants that necessitate expression of the corresponding opsin genes for their preparation. With the aim of preparing such mutants in amounts larger than those currently available by transient transfection of the mammalian COS-1 cell line, alternative expression systems are being explored. In an accompanying paper, the yeast Saccharomyces cerevisiae was investigated for expression of a synthetic opsin gene (1). We now report on the development and use of stable mammalian cell lines for the expression of a synthetic opsin gene and several of its mutants. Stable mammalian cell lines, particularly those derived from HEK293 cells, have been used frequently for expression of a variety of eukaryotic water-soluble and integral-membrane proteins (2-5). The expression of bovine opsin and several of its mutants in these cells has previously been described by Nathans and coworkers (6) (7) (8) . In this paper, stable mammalian cell lines containing a synthetic bovine opsin gene have been derived from a suspension-adapted HEK293 (293S) cell line. The use of a vector (3) designed to target the opsin gene integration into chromosomal regions that favor high level expression has enabled the production of opsin in milligram amounts per liter of the cell cultures grown to saturation. Following reconstitution of the opsin with 11-cis-retinal, rhodopsin has been purified to homogeneity in a single step by immunoaffinity chromatography. By a variety of chemical and functional criteria, 293S rhodopsin has been demonstrated to be indistinguishable from rhodopsin prepared from bovine rod outer segments (ROS). This method has enabled the preparation of a number of opsin mutants in satisfactory amounts.t
MATERIALS AND METHODS
Materials. Frozen bovine retinae were from the J. A. Lawson Co. (Lincoln, NE). Dodecyl-,3-1-maltoside (DM) was from Anatrace (Maumee, OH). Protein A-Sepharose was from Repligen. CNBr-activated Sepharose 4B was from Pharmacia. Where indicated, buffers contained 1 mM each of the protease inhibitors, phenylmethylsulfonyl fluoride, benzamidine, aprotinin, pepstatin A, and leupeptin.
Methods. The preparation of ROS from frozen bovine retinae was as described (9) . Rhodopsin was purified by immunoaffinity chromatography from solubilized ROS membranes or from COS-1 solubilized cell extracts using rho 1D4-Sepharose beads as described (10) , except that the protein was eluted with the C-terminal nonapeptide used at 100 ,uM concentration. Transducin was purified from bleached ROS as described by Fung (11) . The rates of its activation were determined at 19-21°C by measuring the GT(a):[y-35S]GTP complex using the filter binding assay as described (12) . Rhodopsin kinase was purified from bleached ROS as described by Palczewski (13) . Initial rates of rhodopsin phosphorylation were determined using a filter binding assay (R.L.T., C. Creuzenet, P.J.R., and H.G.K., unpublished M-l cm-1 at 500 nm. For spectra after photobleaching, samples were illuminated for 20 sec. using light (A, >495 nm) from a fiber optic light source. The decay of metarhodopsin II was monitored by fluorescence increase as described (14) . Concentrations of reconstituted rhodopsin in solubilized cell extracts were estimated by difference spectral analysis. For this the UV/Vis absorption spectrum of a solubilized sample was recorded. The spectrum was recorded again immediately after photobleaching for 30 sec. The difference between the two spectra at 500 nm was used to calculate the rhodopsin concentration in the sample.
Protein concentration was determined by the procedure of Bradford (15) . For cleavage of the oligosaccharide chains, rhodopsin (0.5 ,ug) was incubated in 10 ,ul with 25 units of PNGase-F for 3 hr at 37°C. SDS/PAGE was carried out according to Laemmli (16) .
Construction of the Expression Plasmid, pACHrhoC. An EcoRI-NotI DNA fragment containing a synthetic bovine opsin gene was excised from pMT4 (17) . Expression vector pACHEnc was kindly provided by A. Shafferman (Israel Institute for Biological Research). This vector is a derivative of the vector described by Velan et al. (3). pACHEnc was digested with EcoRV and Sall, and the single-stranded ends in both the vector and the fragment were filled using the Klenow fragment of DNA polymerase I and dNTPs. The vector DNA was then treated with calf intestinal phosphatase. Both the vector and the opsin fragment were purified by passage through agarose gels and used in blunt-end ligation reactions. The ligation mixtures were then introduced into Escherichia coli (DH1) by the procedure of Inoue et al. (18) . Plasmid DNA was prepared from ampicillin-resistant colonies and analyzed by digestion with KpnI, which cuts asymetrically in the opsin gene and once in the vector. Recombinant plasmids with the opsin gene in the correct orientation were prepared from E. coli cultures using anion exchange columns (Qiagen). The opsin:vector junctions in the final construct ( Fig. 1) were confirmed by DNA sequence analysis using opsin gene primers EX16 and PB9 (19) .
Construction of Stable Cell Lines Containing the Opsin Gene. 293S cells were maintained in a humidified incubator at 37°C under 5% CO2/95% air in DMEM/F12 supplemented with heat-treated FBS (10%), penicillin G (100 units/ml), streptomycin (100 ,ug/ml), and glutamine (292 ,ug/ml). 293S cells were transfected using the method of Chen and Okayama (21) . Briefly, 293S cells in exponential phase were trypsinized and reseeded at a density of 1-2 x 106 cells per 10-cm plate in 10 ml DMEM (supplemented as for DMEM/F12). After 25 hr, one cell plate was treated with the above plasmid DNA as follows. The DNA (30 jig) in 500 ,ul of CaCl2 (0.25 M) was mixed with 500 ,ul of buffer F; the mixture was kept for 1 min at room temperature and then added directly to the 293S cell plate. The cells were then transferred to a humidified incubator and incubated under 3% CO2 at 35°C for 19 hr. The cells were washed once with 10 ml of buffer A, DMEM/F12 (10 ml) was added, and the cells incubated for a further 23 hr under 5% CO2 at 37°C.
They were then trypsinized and replated at about 1 X 106 cells per 10-cm dish and incubated for a further 20 hr. The medium was then replaced with fresh medium containing geneticin and thereafter replaced every 2-3 days until colonies formed 12-15 days later. Colonies were isolated using cloning rings and expanded through 24-well (1 ml), 6-well (3 ml), and finally single 10-cm (10 ml) dishes, Geneticin concentration was maintained throughout these operations. The expression of opsin was then estimated as follows. All procedures were performed on ice or at 4°C. Intact cells were dislodged from a 10-cm dish by washing with 10 ml of buffer A and pelleted by centrifugation. The cells were incubated in the dark in 1 ml of buffer A containing 11-cis retinal (5 ,uM) and protease inhibitors for 2 hr. The cells were then solubilized in 0.7 ml of buffer B containing protease inhibitors. Cell lines producing opsin were then identified by difference spectrum analysis. For opsin mutants, solubilized whole-cell extracts from 24-well plates were first transferred to nitrocellulose by dot-blot and screened by immunodetection using monoclonal antibody rho 1D4 followed by ECL detection. Opsin-positive cell lines were then expanded, and opsin expression levels were quantified by difference spectrum analysis.
Growth of Cells in Suspension and Reconstitution of Opsin with l1-cis-Retinal. Suspension cultures were set up using 1-liter spinner flasks containing 500 ml HB-Gro supplemented with FBS (10%), penicillin, and streptomycin. Cell lines were first grown to confluence in two 15-cm culture dishes containing 25 ml of DMEM/F12 with the appropriate concentration of G418. Spinner flasks were inoculated using 4-6 x 107 cells and incubated for 6-7 days in the absence of geneticin. All further manipulations were performed on ice or at 4°C. Cells from saturated cultures (550 ml) were harvested by centrifugation, washed twice with 50 ml of buffer A, and resuspended in 10 ml buffer A containing protease inhibitors. All further manipulations were performed under dim red light. Cells were incubated with 11-cis-retinal (two 25 jl additions of a 10-mM stock solution) over 3 hr and were then pelleted by centrifugation. Cell pellets were treated with end-over-end mixing for 2 hr in 20 ml of buffer B containing protease inhibitors. The concentration of rhodopsin solubilized in the buffer was estimated by difference spectrum analysis. Immunoafffinity Purification of 293S Rhodopsin. A column (12 mm x 107 mm) (5 ml) was packed with 1.6 ml of rho 1D4-Sepharose beads (binding capacity 0.8-1.0 Zg rhodopsin/rl settled beads). (Typically, the amount of rho 1D4-Sepharose used was about 10% in excess of the total binding capacity needed for the estimated rhodopsin content in the crude extract.) The column was degassed, equipped with upper and lower porous discs (frits), and pre-equilibrated with buffer B (5 ml) prior to use. Subsequent operations were all in the dark. A solution (about 20 ml) of the DM-solubilized rhodopsin from a 550-ml culture was applied to the column and allowed to flow by gravity ('0.6 ml/min). Flow-through was collected in fractions of about 1.5 ml. The column was then washed (gravity flow) using 50 ml of buffer B followed by 13 ml of buffer C. Rhodopsin was eluted using buffer D at a reduced flow rate of about 0.05 ml per min. Fractions (1.3 ml) were collected and the eluant was then changed to buffer E for collection of further fractions.
RESULTS

293S Stable Cell Lines Expressing
Opsin. The vector pACHrhoC (Fig. 1) was constructed by replacing the human acetylcholinesterase gene in vector pACHEnc (3) with the synthetic opsin gene. This vector was determined by restriction analysis to contain the opsin gene downstream from the cytomegalovirus promoter/enhancer and upstream from the simian virus 40 poly(A) sequence. The correctness of the junctions at both 5' and 3' ends of the opsin gene with the vector DNA was confirmed by sequence analysis. This plasmid was used for stable transfection of the 293S cell line, and selection was with geneticin at concentrations of 0.8, 1.0, or 2.0 mg/ml. Resulting colonies were expanded to 10-cm culture dishes, and the total cells thus obtained were tested for opsin content. This was done by the standard treatment with 11-cisretinal, solubilization in buffer B, and analysis by the difference spectrum analysis of the absorption spectra in light and in dark. Typically, 40-50% of the G418r cell lines were positive for opsin production but showed a range of expression levels. The maximum expression level obtained using 0.8 mg/ml of G418 selection was 9 pLg of rhodopsin per 10- identified by dot-blot analysis before quantitation by difference spectrum analysis.
293S Cell Growth in Suspension and Rhodopsin Purification. The conditions for cell growth in suspension (2) were modified by using the richer HB-Gro (Irvine Scientific) medium supplemented with 10% FBS. A 550-ml culture of the cell line was harvested, treated with 1 1-cis-retinal, and solubilized 0. in buffer B. Difference spectrum analysis showed a rhodopsin content of 1.37 mg in the total solubilized extract (20 ml), which was applied to a rho 1D4-Sepharose and purification carried out as described in Materials and Methods. Successive washings and elusions with different buffers were as shown in Fig. 2 . Selected fractions were examined by SDS/PAGE, and the proteins were visualized both by silver staining (Inset A) and by immunoblotting (Inset B).
As seen both in the elusion profile and SDS/PAGE analysis, rhodopsin eluted sharply in three fractions (59-61, all with A280/A50o ratios between 1.6-1.73 (1.1 mg) and with a total recovery of 1.25 mg (91% of estimated expressed amount).
Characterization of 293S Rhodopsin. The UVivisible absorption spectra. The spectra, in the dark (A28o/A50o); 1.65 and after photobleaching, are shown in Fig. 3 . These are identical to those for rhodopsin purified from ROS. Furthermore, the rate of metarhodopsin II decay as shown in Fig. 3 Inset (T112, 15 min, 20°C) was indistinguishable from that of ROS rhodopsin (14) .
Transducin activation by 293S rhodopsin. Initial rates of activation of transducin were measured (at 2-10 nM concentrations) by GT(a): [y-35S]GTP complex formation. The results are shown in Fig. 4 . Regression analysis performed on the data sets of ROS and 293S rhodopsin over five rhodopsin concentrations shows that the averaged initial rate values are essentially identical.
Light-dependent phosphorylation of 293S rhodopsin by rhodopsin kinase. Rates of phosphorylation of 293S rhodopsin and ROS rhodopsin were measured after illumination. The initial rates of phosphate incorporation, as determined by the slope (Fig. 5) , were similar for both rhodopsins.
SDS/PAGE analysis and glycosylation profile of 293S rhodopsin. As shown above (Fig. 2) in SDS/PAGE analysis of fractions, purified 293S rhodopsin migrates as a smear and much slower than ROS rhodopsin (Fig. 6) .
Preparations of ROS rhodopsin and 293S rhodopsin were digested with PNGase-F and the products analyzed as in Fig.  6 . All three deglycosylated rhodopsins migrated identically (lanes 3, 5, and 7) with an apparent molecular mass of about 30 kDa. The slower bands observed in every case with identical mobility probably correspond to the dimers of the deglycosylated rhodopsins. Therefore, differences in mobilities of the three rhodopsins result from different N-glycosylation patterns. in Fig. 2 for wild-type rhodopsin. In Fig. 7, the majority (23) (24) (25) and in this laboratory (S. Kaushal, unpublished work). In our view, this system has not resulted in any improvement in the availability of fully functional posttranslationally processed protein that can be reliably used in signal transduction studies.
The mammalian stable cell lines now developed have enabled the preparation of rhodopsin and several of its mutants in amounts much larger than those previously thought practical. Furthermore, there is the efficient single-step purification procedure that results in homogeneous proteins in concentrated form. The applicability of these methods should be further extended by straightforward scale-up of the entire procedure for larger amounts of a variety of mutants that will be needed in future studies. A particularly critical advantage of the mammalian systems resides in the likelihood that they will perform specific post-translational modifications required for correct folding and function.
One property of the expressed proteins now characterized that became evident was the difference in electrophoretic mobility from those previously observed for ROS or COS cell produced rhodopsins. This was clearly the result of different N-glycosylation characteristics of the mammalian cell lines. However, stringent analysis of the expressed wild-type rhodopsin produced by all the methods available at present revealed no difference in function from ROS rhodopsin.
In conclusion, progress has been made in high level opsin gene expression and efficient purification of rhodopsin. The methods described should enable convenient scale-up of production and allow the preparation of a variety of mutants of interest in structure-function studies of rhodopsin.
